Skip to main content
. 2019 Jan 8;11:469. doi: 10.3389/fnmol.2018.00469

Figure 5.

Figure 5

Inhibition of MCU via the pharmacological inhibitor Ru360 or siMCU attenuated noise-induced increases in cleaved caspase 9 (CC9) in OHCs of the basal turn. (A) Representative images show an increase in immunoreactivity for CC9 (red) in OHCs stained with phalloidin 1 h after completion of the exposure (panel 2) compared to control mice without exposure (panel 1). Treatment with Ru360 attenuated noise-induced CC9 in OHCs (panel 3). Images were taken from the region of the surface preparations corresponding to sensitivity to 22–32 kHz using a Leica SP5 confocal microscope; scale bar = 10 μm. (B) Quantification of CC9 in OHCs confirmed a significant increase after noise exposure and attenuation of this increase with Ru360 treatment; n = 4 per group with one cochlea used per mouse. Data are presented as means + SD, **p < 0.01. (C) Representative images show that pretreatment with siMCU decreases immunoreactivity for CC9 (red) in OHCs stained with phalloidin (green) 1 h after completion of the exposure compared to siControl treatment. Images were taken from the region of the surface preparations corresponding to sensitivity to 22–32 kHz using a Zeiss confocal microscope; scale bar = 10 μm. (D) Pretreatment with siMCU also significantly reduced noise-increased immunolabeling for CC9 in OHCs compared to mice exposed to scrambled siRNA (siControl). Data are presented as means + SD, n = 4 per group with one cochlea used per mouse, *p < 0.05.